LICN — Lichen International Income Statement
0.000.00%
Last trade - 00:00- $2.17m
- -$20.40m
- $41.48m
Annual income statement for Lichen International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 30.7 | 34.3 | 33.8 | 39.8 | 41.5 |
| Cost of Revenue | |||||
| Gross Profit | 18.8 | 20.5 | 20.2 | 24.3 | 25.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 21.9 | 23 | 23.2 | 27.5 | 46 |
| Operating Profit | 8.79 | 11.3 | 10.6 | 12.3 | -4.55 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9 | 11.5 | 10.7 | 11.6 | -4.17 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.41 | 8.46 | 7.82 | 8.34 | -6.12 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.41 | 8.46 | 7.82 | 8.34 | -6.14 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.41 | 8.46 | 7.82 | 8.34 | -6.14 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 48.4 | 63.9 | 69.5 | 64 | -34.9 |
| Dividends per Share |